Louis Cannon, MD, is the Founder and Senior Managing Director of BioStar Capital. See sector focus and contact routes.
Louis Cannon, MD, is the Founder and Senior Managing Director of BioStar Capital, a venture firm he established in 2005 after serving as an interventional cardiologist and president of the Cardiac & Vascular Research Center of Northern Michigan. His investment thesis targets early- and late-stage companies in the United States that develop transformative medical technologies, with a specific focus on the cardiovascular, orthopedics, and robotics sectors. The firm typically deploys check sizes ranging from $1 million to $10 million and integrates key opinion leader physicians into its General Partner model to provide clinical validation. Notable portfolio companies include AorTx, Inc., which Cannon chaired before its acquisition by a public company, and Setagon, where BioStar was the lead investor prior to a Fortune 100 acquisition. Cannon also serves on the boards of CardioVascular Ingenuity and Kona, leveraging his background as a principal investigator for landmark cardiovascular trials. A distinctive point of his approach is the “doctor as investor” model, which he describes as a new paradigm where physicians actively invest in the future of medicine rather
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Petoskey.
Investors like Louis Cannon · Full investor directory · Investor access · Company funding database